The Diabetes Trials Unit was established to study new medications for patients with diabetes. Studies enroll both type 1 and type 2 diabetics to study the effects of the newly introduced or developing medications such as inhaled insulin and incretin-mimetic agents. The goal of the Unit is to establish the best form of medications for our patients both today and in the future.